Skip to main content
. 2021 Sep 20;7:255. doi: 10.1038/s41420-021-00649-z

Fig. 7. DLGAP1-AS2 regulated GC progression via Six3/Wnt1/β-catenin signaling pathway in vivo.

Fig. 7

A Tumor samples and growth curves from sh-NC, sh-DLGAP1-AS2, sh-DLGAP1-AS2 + sh-Six3, and sh-DLGAP1-AS2 + sh-Six3 + LF3 groups were shown (n = 6 for each group). B Tumor weight from the respective groups was represented. C RT-qPCR analysis of DLGAP1-AS2, Six3, Wnt1, Slug, Myc, cyclinD1, MMP2, MMP9, E-cadherin, and N-cadherin in xenograft tumors for each group. D IHC assays of Wnt1, E-cadherin, N-cadherin, Slug, Ki-67, and Six3 in paraffin tumor sections for each group. Scale bar: 50 μm. *P < 0.05.